Secondary |
Drug Use For Unknown Indication |
37.2% |
Product Used For Unknown Indication |
30.9% |
Depression |
5.3% |
Sleep Disorder |
4.3% |
Suicide Attempt |
4.3% |
Arthralgia |
2.1% |
Back Pain |
2.1% |
Eating Disorder |
2.1% |
Low Back Pain |
2.1% |
Self Injurious Behaviour |
2.1% |
Staphylococcal Infection |
2.1% |
Essential Hypertension |
1.1% |
Hypertension |
1.1% |
Hypothyroidism |
1.1% |
Periprosthetic Fracture |
1.1% |
Psychotic Disorder |
1.1% |
|
Self Injurious Behaviour |
17.1% |
Suicide Attempt |
17.1% |
Acute Respiratory Distress Syndrome |
5.7% |
Aggression |
5.7% |
Drug Exposure During Pregnancy |
5.7% |
Hyperkalaemia |
5.7% |
Inappropriate Antidiuretic Hormone Secretion |
5.7% |
Renal Failure Acute |
5.7% |
Respiratory Failure |
5.7% |
Abortion Spontaneous |
2.9% |
Exposure During Pregnancy |
2.9% |
Foetal Growth Restriction |
2.9% |
Liver Injury |
2.9% |
Medication Error |
2.9% |
Multiple Congenital Abnormalities |
2.9% |
Pregnancy |
2.9% |
Sopor |
2.9% |
Vomiting |
2.9% |
|
Concomitant |
Drug Use For Unknown Indication |
14.0% |
Pain |
10.7% |
Asthma |
8.2% |
Product Used For Unknown Indication |
8.2% |
Depression |
7.7% |
Hypertension |
6.6% |
Osteoporosis |
5.8% |
Sleep Disorder |
4.9% |
Insomnia |
4.1% |
Schizophrenia, Paranoid Type |
3.8% |
Psychotic Disorder |
3.6% |
Bipolar Disorder |
3.3% |
Diabetes Mellitus |
3.3% |
Rheumatoid Arthritis |
3.0% |
Anxiety |
2.7% |
Hypothyroidism |
2.7% |
Mental Disorder |
2.2% |
Constipation |
1.6% |
Gastritis |
1.6% |
Pain In Extremity |
1.6% |
|
Weight Decreased |
10.2% |
Femur Fracture |
8.5% |
Pneumonia |
8.5% |
Tachycardia |
8.5% |
Myelodysplastic Syndrome |
6.8% |
Weight Increased |
6.8% |
Dysuria |
5.1% |
Urinary Tract Infection |
5.1% |
Exposure During Pregnancy |
3.4% |
Hyposmia |
3.4% |
Hypothermia |
3.4% |
Neoplasm Malignant |
3.4% |
Parkinsonism |
3.4% |
Peripheral Arterial Occlusive Disease |
3.4% |
Pruritus |
3.4% |
Pulmonary Embolism |
3.4% |
Reflux Gastritis |
3.4% |
Serotonin Syndrome |
3.4% |
Sleep Disorder |
3.4% |
Small For Dates Baby |
3.4% |
|
Interacting |
Drug Use For Unknown Indication |
44.4% |
Sleep Disorder |
22.2% |
Depression |
16.7% |
Pain |
16.7% |
|
Sleep Disorder |
42.9% |
Drug Interaction |
14.3% |
Regurgitation |
14.3% |
Respiratory Depression |
14.3% |
Respiratory Failure |
14.3% |
|